BioCardia, Inc. is a clinical stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. Its lead therapeutic candidate is the CardiAMP cell therapy system and its second therapeutic candidate is the CardiALLO cell therapy system. BioCardia is headquartered in San Carlos, California.
Quote | BioCardia Inc. (OTCMKTS:BCDA)
Last: | $ |
---|---|
Change Percent: | 3.10% |
Open: | $4.73 |
Close: | $4.66 |
High: | $4.73 |
Low: | $4.6348 |
Volume: | 2,064 |
Last Trade Date Time: | 02/12/2020 04:27:18 pm |
News | BioCardia Inc. (OTCMKTS:BCDA)
SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP&...
SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced completion of enrollment and collection of the primary endpoint results of t...
Message Board Posts | BioCardia Inc. (OTCMKTS:BCDA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $BCDA News Article - BioCardia Letter to Shareholders | whytestocks | investorshangout | 12/22/2022 4:15:44 PM |
whytestocks: $BCDA News Article - BioCardia Reports Third Quarter 2022 Business Highlights and Finan | whytestocks | investorshangout | 11/09/2022 9:15:53 PM |
whytestocks: $BCDA News Article - BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Tr | whytestocks | investorshangout | 10/03/2022 4:50:59 PM |
whytestocks: $BCDA News Article - BioCardia to Participate in Cantor Fitzgerald's Cell and Genetic M | whytestocks | investorshangout | 09/08/2022 5:30:48 PM |
whytestocks: $BCDA News Article - BioCardia Announces Positive DSMB Review and Recommendation to Con | whytestocks | investorshangout | 08/31/2022 2:20:49 PM |
News, Short Squeeze, Breakout and More Instantly...
SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP&...
SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced completion of enrollment and collection of the primary endpoint results of t...
The Dow Jones index closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern aro...